ALKS vs BDX · P/E 14, rev $1.56B vs P/E 34, rev $21.84B
Alkermes Plc (ALKS) versus Becton Dickinson and Company (BDX) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Not investment advice. Open the ALKS and BDX stock pages for the full models.
Not investment advice.